Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-05-18 @ 5:48 PM
Study NCT ID:
NCT05585034
Status:
COMPLETED
Last Update Posted:
2025-08-07
First Post:
2022-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
Sponsor:
Organization: